Clone 106 targets a unique Brucella abortus epitope, providing strong specificity and high‑signal detection in ELISA and Western blotting. Its robust affinity supports pathogen monitoring, antigen characterization, and diagnostic assay development. MBCA‑55A‑106 offers low nonspecific binding and reproducible performance, making it valuable for laboratories studying Brucella infection dynamics, immune response, and vaccine‑related antigen profiling